Director/PDRM shareholding

April 10, 2008 Group News

Director’s Dealings

Cryo-Save Group N.V. (the “Company”) announces that it was notified on 9 April 2008 that Johan Goossens, a Non-Executive Director of the Company, yesterday purchased 1,450,000 ordinary shares in the Company at 160 pence per ordinary share. These shares were purchased from HTB N.V., a company which Johan Goossens controls. As a result of this transaction Johan Goossens’ total beneficial interest in the Company remains unchanged. Johan Goossens is beneficially interested in 6,410,635 ordinary shares in the Company representing 13.61 per cent. of the issued share capital.

read more

Director/PDMR shareholding

December 10, 2007 Group News

Cryo-Save Group N.V. (“Cryo-Save” or “the Company”), Europe’s largest adult stem cell storage bank, announces that on 7 December 2007 the Company granted options to subscribe for ordinary shares in the Company under the Cryo-Save Group 2007 Share Option Scheme. The Company granted 225,000 options to Directors of the Company (as detailed below) and 115,000 options to certain other employees of the Company all at an exercise price of 221p per share, being the price equal to the arithmetic average of the closing mid-market price over the five dealing days prior to the date of the grant.

read more